α-Smooth Muscle Actin as Predictors of Early Recurrence in Early-Stage Ductal Type Breast Cancer After Mastectomy and Chemotherapy
2024

Role of α-Smooth Muscle Actin in Breast Cancer Recurrence

Sample size: 25 publication

Author Information

Author(s): Palo Seetu

Primary Institution: All India Institute of Medical Sciences, Bibinagar, Telangana, India

Hypothesis

Is α-smooth muscle actin (α-SMA) a predictive biomarker for early recurrence in invasive ductal adenocarcinoma of the breast?

Conclusion

The study suggests that α-SMA may have implications for predicting early recurrence in breast cancer, but further analysis is needed.

Supporting Evidence

  • High α-SMA expression was observed in six cases in the 'without recurrence' group, which is 24% of the cohort.
  • The study highlights the need for further analysis of clinicopathological parameters to understand tumor biology better.

Takeaway

This study looks at a protein called α-SMA to see if it can help predict if breast cancer will come back after treatment.

Methodology

The study used a cross-sectional immunohistochemical approach to assess α-SMA expression.

Limitations

The study lacks detailed follow-up data and specific clinicopathological parameters that could affect the results.

Digital Object Identifier (DOI)

10.30699/ijp.2024.2022442.3255

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication